Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle

• Published in: The Journal of pharmacology and experimental therapeutics Vol. 350; no. 3; pp. 681 - 690
• Main Authors: Moltzau, Lise Román, Aronsen, Jan Magnus, Meier, Silja, Skogestad, Jonas, Ørstavik, Øivind, Lothe, Gustav B, Sjaastad, Ivar, Skomedal, Tor, Osnes, Jan-Bjørn, Levy, Finn Olav, Qvigstad, Eirik
• Format: Journal Article
• Language: English
• Published: United States 01.09.2014
• Subjects: Animals; Cells, Cultured; Heart Failure - drug therapy; Heart Failure - metabolism; Heart Failure - pathology; Male; Myocytes, Cardiac - drug effects; Myocytes, Cardiac - metabolism; Myocytes, Cardiac - pathology; Natriuretic Peptide, Brain - metabolism; Natriuretic Peptide, Brain - pharmacology; Natriuretic Peptide, Brain - therapeutic use; Natriuretic Peptide, C-Type - metabolism; Natriuretic Peptide, C-Type - pharmacology; Natriuretic Peptide, C-Type - therapeutic use; Organ Culture Techniques; Rats; Rats, Wistar; Ventricular Dysfunction, Left - drug therapy; Ventricular Dysfunction, Left - metabolism; Ventricular Dysfunction, Left - pathology
• ISSN: 0022-3565; 1521-0103
• DOI: 10.1124/jpet.114.214882

We previously found a negative inotropic (NIR) and positive lusitropic response (LR) to C-type natriuretic peptide (CNP) in the failing heart ventricle. In this study, we investigated and compared the functional responses to the natriuretic peptides (NPs), brain (BNP) and C-type natriuretic peptide (CNP), and relate them to cGMP regulation and effects on downstream targets. Experiments were conducted in left ventricular muscle strips and ventricular cardiomyocytes from Wistar rats with heart failure 6 weeks after myocardial infarction. As opposed to CNP, BNP did not cause an NIR or LR, despite increasing cGMP levels. The BNP-induced cGMP elevation was mainly and markedly regulated by phosphodiesterase (PDE) 2 and was only marginally increased by PDE3 or PDE5 inhibition. Combined PDE2, -3, and -5 inhibition failed to reveal any functional responses to BNP, despite an extensive cGMP elevation. BNP decreased, whereas CNP increased, the amplitude of the Ca(2+) transient. BNP did not increase phospholamban (PLB) or troponin I (TnI) phosphorylation, Ca(2+) extrusion rate constant, or sarcoplasmatic reticulum Ca(2+) load, whereas CNP did. Both BNP and CNP reduced the peak of the L-type Ca(2+) current. Cyclic GMP elevations by BNP and CNP in cardiomyocytes were additive, and the presence of BNP did not alter the NIR to CNP or the CNP-induced PLB and TnI phosphorylation. However, a small increase in the LR to maximal CNP was observed in the presence of BNP. In conclusion, different responses to cGMP generated by BNP and CNP suggest different compartmentation of the cGMP signal and different roles of the two NPs in the failing heart.